National and Kapodistrian University of Athens
Ο ρόλος των επιπέδων TIMPs στον ορό ασθενών με καρκίνο του παχέος εντέρου
Abstract
dc:descriptionColorectal cancer (CRC) is the fourth most commonly diagnosed cancer andthe second leading cause of cancer-related deaths in industrialized word. Life qualityand expectancy of CRC patients depends on the selected treatment decided upon thetumor stage at the time of diagnosis and the monitoring of treatment efficacy.Biological markers for early detection, selection of patients who will benefit the mostfrom any available treatment and monitoring the efficacy of this treatment, will helpto improve the quality of life and increase the disease-free survival and overallsurvival of these patients. Tissue inhibitors of metalloproteinases (TIMPs) are suchbiomarkers.TIMPs are endogenous regulators of matrix metalloproteinases (MMPs), themajor enzymes that are involved in extracellular matrix remodeling. It is proven thatloss or dysfunction of regulation of extracellular matrix remodeling process is thehallmark of many pathological conditions like cancer. Furthermore, MMPs areinvolved in tumor growth and progression with mechanisms independent of theircatalytic function on extracellular matrix components, exhibiting also pro- and antitumorigenicactivities. This complex role of MMPs extends to the TIMPs.Furthermore, it is proven that TIMPs posses functions that are MMP-independent,influencing cellular proliferation, apoptosis and neoangiogenesis, processes that areimportant in neoplastic diseases.Many studies prove that MMPs and TIMPs through their MMP-dependent andMMP-independent actions, play a crucial role in CRC growth and progression. Basedon those observations, investigators have focused on measurement of TIMPs intissues and body fluids, and on relations of TIMPs with clinicopathologicalparameters.TIMP-1 and to a laser extend TIMP-2, are the most studied TIMPs in CRCpatients with contradictory sometimes, results. At the present study we simultaneouslyassess serum levels of TIMP-1 and TIMP-2 in colon cancer patients and correlatethem with age, gender, disease stage, histopathological grade and patient survival.The aim of the study was to establish the diagnostic and prognostic utility of TIMP-1and TIMP-2 serum levels.In agreement with other studies, we showed that enhanced TIMP-1 serumlevels were associated with advanced disease stage and with poorly differentiated tumors. In the case of TIMP-2, no significant association with disease stage andhistopathological grade were noted. Additionally, analysis of the results renderedserum TIMP-1 concentration an independent prognostic factor and correlate enhancedlevels with poor overall survival. Colon cancer patients with elevated serum TIMP-2levels had shorter overall survival, although without reaching statistical significance.In a subgroup of patients with well and moderately differentiated tumors, weidentified both TIMP-1 and TIMP-2 as independent prognostic factors. However,neither TIMP-1 nor TIMP-2 was associated the survival of patients with Dukes’ stageA+B tumors.Conclusively, we verified the diagnostic and prognostic utility of serumTIMP-1 levels in patients with colon cancer. TIMP-2 was found to be an independentprognostic factor in the a subgroup of patients with well and moderately differentiatedtumors, without being associated with disease stage and tumor histopathologicalgrade. Further studies need to be done in order to establish the clinical importance ofTIMPs in CRC patients and their utility in the prediction of response to varioustreatments.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2013
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Tsakoniatis, Michail
- Τσακωνιάτης, Μιχαήλ
Subjects
dc:subject × 16- Καρκίνος παχέος εντέρου
- Ορός αίματος
- Μεταλλοπρωτεϊνάσες εξωκυττάριας ουσίας
- Ιστικοί αναστολείς μεταλλοπρωτεϊνασών (TIMPs)
- Εξωκυττάρια ουσία
- Colorectal cancer
- Serum
- Matrix metalloproteinases
- Tissue inhibitors of matrix metalloproteinases
- Extracellular matrix
- Ιατρική και Επιστήμες Υγείας
- Βασική Ιατρική
- Κλινική Ιατρική
- Medical and Health Sciences
- Basic Medicine
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/39416